- Home
- TALK vs PACB Comparison
TALK vs PACB Comparison
Compare TALK & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- PACB
- Stock Information
- Founded
- TALK 2012
- PACB 2000
- Country
- TALK United States
- PACB United States
- Employees
- TALK N/A
- PACB N/A
- Industry
- TALK Medical/Nursing Services
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- TALK Health Care
- PACB Industrials
- Exchange
- TALK Nasdaq
- PACB Nasdaq
- Market Cap
- TALK 534.6M
- PACB 451.9M
- IPO Year
- TALK N/A
- PACB 2010
- Fundamental
- Price
- TALK $3.36
- PACB $1.43
- Analyst Decision
- TALK Buy
- PACB Buy
- Analyst Count
- TALK 5
- PACB 13
- Target Price
- TALK $4.38
- PACB $2.85
- AVG Volume (30 Days)
- TALK 1.1M
- PACB 10.5M
- Earning Date
- TALK 02-20-2025
- PACB 02-13-2025
- Dividend Yield
- TALK N/A
- PACB N/A
- EPS Growth
- TALK N/A
- PACB N/A
- EPS
- TALK N/A
- PACB N/A
- Revenue
- TALK $181,291,000.00
- PACB $173,147,000.00
- Revenue This Year
- TALK $28.22
- PACB N/A
- Revenue Next Year
- TALK $23.48
- PACB $19.89
- P/E Ratio
- TALK N/A
- PACB N/A
- Revenue Growth
- TALK 31.50
- PACB 2.14
- 52 Week Low
- TALK $1.60
- PACB $1.16
- 52 Week High
- TALK $3.92
- PACB $6.83
- Technical
- Relative Strength Index (RSI)
- TALK 53.87
- PACB 34.10
- Support Level
- TALK $2.92
- PACB $1.40
- Resistance Level
- TALK $3.24
- PACB $1.65
- Average True Range (ATR)
- TALK 0.13
- PACB 0.13
- MACD
- TALK 0.01
- PACB -0.03
- Stochastic Oscillator
- TALK 74.36
- PACB 6.56
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.